SIETES :: 91846 citas

Resultados de la búsqueda por ANALGÉSICOS REFINAR BÚSQUEDA

1.

Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf 2017;26:635-41. [Ref.ID 101626]

2.

Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]

3.

The Data Team. Millennials are less keen than previous generations on illicit drugs. They are taking up painkillers instead. The Economist 2017:1. [Ref.ID 101607]

4.

Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]

5.

Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]

6.

Mudd PA, Thottathil P, Giordano T, Wetmore RF, Elden L, Jawad AF, Ahumada L, Gálvez JA. Association between ibuprofen use and severity of surgically managed posttonsillectomy hemorrhage. JAMA Otolaryngol Head Neck Surg 2017:4 de mayo. [Ref.ID 101564]

7.

Anónimo. Congressional representatives warn WHO of Purdue Pharma’s global push. DIA Daily 2017:3. [Ref.ID 101563]

8.

Anónimo. Cherokee nation sues drug distributors, pharmacies for spreading addictive opioids medications. DIA Daily 2017:1. [Ref.ID 101538]

9.

Grosser T. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2017;376:1389-90. [Ref.ID 101526]

10.

Attal N, Barrot M. Is pregabalin ineffective in acute or chronic sciatica?. N Engl J Med 2017;376:1169-70. [Ref.ID 101504]

11.

Prada-Ramallal G, Takkouche B, Figueiras A. Diverging conclusions from the same meta-analysis in drug safety: source of data (primary versus secondary) takes a toll. Drug Saf 2017;40:351-8. [Ref.ID 101501]

12.

Anónimo. Litigation is new tactic in opioid crisis. DIA Daily 2017:1. [Ref.ID 101500]

13.

Karaca-Mandic P, Meara E, Morden NE. The growing problem of co-treatment with opioids and benzodiazepines. BMJ 2017;356:j1224. [Ref.ID 101495]

14.

Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 2017;356:j760. [Ref.ID 101494]

15.

Mathieson S, Chiro M, Maher CG, LcLachlan AJ, Latimer J, Koes BW, Hancock MJ, Harris I, Day RO, Billot L, Pik J, Jan S, Lin C-WC. Trial of pregabalin for acute and chronic sciatica. N Engl J Med 2017;376:1111-20. [Ref.ID 101483]

16.

Anónimo. AINS: infections des tissus mous et complications suppuratives de pneumopathies bactériennes. Prescrire 2017;37:109. [Ref.ID 101429]

17.

Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet 2017;389:736-47. [Ref.ID 101426]

18.

Machado GC, Maher CG, Herreira PH, Day RO, Pinheiro MB, Ferreira ML. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis 2017:2 de febrero. [Ref.ID 101391]

19.

Felson DT. Safety of nonsteroidal antiinflammatory drugs.. N Engl J Med 2016;373:2595-6. [Ref.ID 101348]

20.

Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME. Toxina botulínica en la neuralgia del trigémino. Med Clin (Barc) 2017;148:28-32. [Ref.ID 101340]